Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based CEO’ operating in the Health Care space. If you think a CEO’ is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Rakesh Kapoor
CEO of Reckitt
Rakesh Kapoor joined Reckitt & Colman in 1987, serving in various roles including Regional Sales Manager, North India, General Manager, Indian Southern Region and Regional Marketing Director, South Asia. In 1999, he was appointed Global Category Director, Pest Control. Following the merger, he assumed the role of, Senior Vice President, Home Care. He was appointed SVP, Regional Director, Northern Europe in 2001 and in July 2006, he was promoted to EVP, Category Development. Rakesh became CEO in September 2011
Follow Rakesh Kapoor:
About Reckitt: Reckitt Benckiser Group is a consumer goods company makes health, hygiene and home products.
_______
Yusuf Sherwani
Co-Founder & CEO of Quit Genius
Yusuf is the Co-Founder and CEO of Quit Genius. He is a Y Combinator alumni and was featured by Fast Company’s as one of their Most Creative People of 2019 as well as Forbes’ 30 Under 30 List of 2018.
Follow Yusuf Sherwani:
About Quit Genius: Quit Genius is pioneering digital therapeutics for multiple addictions.
Andre Chow
Co-Founder & Co-CEO of Digital Surgery
Andre is a General Surgeon, Web coder, UX designer and all-round hacker. He has a BSc in Surgical Technology, a PhD in Tissue Engineering and leads Operations & Product. When not in the lab, Andre spends his spare time playing a variety of sports, and trying to push his french bulldog off the sofa.
Follow Andre Chow:
About Creative Destruction Lab (CDL), Digital Surgery, Medtronic, Touch Surgery: Digital Surgery is a privately-held pioneer in surgical artificial intelligence (AI), data and analytics, and digital education and training
Valentina Milanova
Founder and CEO of Daye
Valentina previously worked with Techstars as a Business Development Associate. She is currently looking after the AI portfolio at Founders Factory – launching 200 businesses in the next five years! Before entering the startup and VC worlds, Valentina studied law and worked as a technology correspondent for large international publications.
Follow Valentina Milanova:
About Daye: Daye creates category-defining products and services that set a new standard for medical research and scientific innovation.
Humphrey Cobbold
Chief Executive Officer of Pure Gym
Humphrey Cobbold is the chief executive officer at Pure Gym. He is a former chief executive officer at Wiggle. Humphrey holds an MBA from INSEAD.
Follow Humphrey Cobbold:
About Pure Gym: PureGym is a gym operator that provides affordable and convenient access to fitness facilities in the U.K.
Emma Sceats
CEO of Isogenica
Dr Sceats joined CN Bio Innovations in 2010 as Commercial Manager to spearhead the organisation’s sales, marketing and business development activities. She has led sales and partnering initiatives with major pharmaceutical organisations and overseen academic research and licensing programs, including with the Massachusetts Institute of Technology (MIT) that have led to the development of the company’s leading products. Dr Sceats was promoted to Chief Operating Officer in May 2013 with responsibility for the day-to-day running of the company, focussing on delivering the objectives of company investors. Dr Sceats holds degrees from Oxford and Bristol Universities (UK) and the Massachusetts Institute of Technology, where she studied Chemistry. Her previous roles include working as a research scientist at E.I. DuPont de Nemours (Wilmington, DE, USA) and in intellectual property management and licensing for the University of Oxford.
Follow Emma Sceats:
About Isogenica: Isogenica operates a range of discovery platforms supported by state-of-the-art methodologies for identifying antibody and peptide ligands.
Emmanuel Ligner
President & CEO, Life Sciences of GE Healthcare
Emmanuel joined GE Healthcare in April 2008, following its acquisition of Whatman International Plc. Since 2008, Emmanuel has held various positions in GE Healthcare Life Sciences. Working both in the UK and in the US, he managed the North America BioProcess business. In January 2012, Emmanuel took charge of the Commercial part of the then Life Sciences business, across EMEA, later expanding his role to include global commercial leadership of BioProcess. In January 2016, Emmanuel was name General Manager of the Core Imaging business which he held until he was named President and CEO of Life Sciences In July 2017. Emmanuel first entered the biopharma industry in Japan, joining Ostuka Pharmaceutical International Ltd as a Medical Representative in Tokyo. After five years in Ostuka in various roles, Emmanuel joined Abbott Japan, occupying positions such as Marketing Director Diagnostic Division and Commercial Director Diabetes Care Division. After 10 years in Japan, Emmanuel moved to the UK as Vice President Sales & Marketing Europe for Whatman International Plc.
Follow Emmanuel Ligner:
About Cytiva, GE Healthcare: GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care.
Jan Makela
President and CEO, Imaging at GE Healthcare of GE Healthcare
Jan Makela is the President & CEO of GE Healthcare Global Services. Appointed in December 2017, he oversees the global development and execution of GE Healthcare’s service solutions and operations around the globe.
Follow Jan Makela:
About GE Healthcare: GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care.
Kieran Murphy
President & CEO of GE Healthcare
Kieran Murphy is President and CEO of GE Healthcare, a $20 billion business unit of General Electric that provides transformational medical technologies and solutions to the global healthcare industry. GE Healthcare supports customers in over 100 countries with a broad range of services and systems, from diagnostic imaging and healthcare IT through to molecular diagnostics and life-sciences. Prior to this, Kieran was President and Chief Executive Officer of GE Healthcare Life Sciences, a $3.7 billion molecular medicine business that provides a broad range of industry-leading technologies and services for drug discovery, pre-clinical and clinical development and biopharmaceutical manufacturing, as well as molecular tools for diagnostics, therapy selection and treatment monitoring in patient care. Kieran was appointed CEO in May 2011 and oversaw significant revenue growth and geographic expansion of the molecular medicine business. Kieran joined GE Healthcare in 2008 from Whatman plc, a $230 million global supplier of filters and membranes for laboratory research, life sciences and medical diagnostic applications. Kieran has over twenty years’ experience in the global life sciences and biotechnology industry, beginning his career with Janssen Pharmaceutical, a division of Johnson and Johnson, followed by leadership roles with Mallinckrodt, veterinary medicines provider Vericore, Novartis, Adprotech, ML Laboratories and Innovata plc.
Follow Kieran Murphy:
About GE Healthcare: GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care.
Rudy Benfredj
Co-Founder & CEO of Mendelian
Follow Rudy Benfredj:
About Mendelian: Mendelian is helping doctors diagnose rare genetic diseases faster.
Furquan Kidwai
Founder & CEO of Dawaai
Furquan Kidwai is an entrepreneur building a pharmacy for emerging Asia. Prior to this journey, Kidwai was an investment banker for over eight years in London where, in his last role, he was the Head of CEEMEA Financing as well as a Senior Vice President in the Fixed Income business at the Royal Bank of Scotland. Before joining RBS, Mr. Kidwai worked at Merrill Lynch and Lehman Brothers in their London and New York offices. Mr. Kidwai has a Master’s degree in International Relations from Cambridge University. He also holds an MSc in Financial Engineering & Risk Management from Imperial College London and BEng (Hons) in Electrical and Computer Engineering from the University of Bristol.
Follow Furquan Kidwai:
About Dawaai: Dawaai operates as a digital health platform with an online network of pharmacies and generic medicine.
Jean-luc Bressard
CEO of Hextransforma Healthcare
Social equality campaigner and entrepreneur
Follow Jean-luc Bressard:
About Dolerite Ltd, Hextransforma Healthcare, Time to Shine Kids: Telemedicine and digital healthcare solution provider. Owner of the Brit-Med.com medical tourism platform
Riya Grover
Co-Founder and CEO of Feedr
Riya Grover is the founder and CEO of Feedr, a scalable technology platform empowering healthy and artisan food vendors to produce and supply meals for the workplace.
Follow Riya Grover:
About Feedr: Feedr is an enterprise food technology platform that gives corporate customers software to support healthier daily eating in workplaces
Alon Laniado
Founder & CEO of FITMATE Coach
Alon Laniado is a Founder and CEO at Fitmate and the Founder and Chairman of Eternity Capital & Ventures. Prior to that, he was the Co-Founder of PathMotion (sold to PageUp).
Follow Alon Laniado:
About FITMATE Coach: Online personal 1:1 health coaching
Peter Hames
Co-Founder & CEO of Big Health
Peter Hames is CEO of Big Health, a digital medicine company he co-founded with clinical psychologist Prof Colin Espie (University of Oxford). Big Health creates automated behavioral medicine programs fuelled by tracked data, and was inspired by Peter’s difficulty in getting access to evidence-based non-drug solutions to his own insomnia. Big Health’s first product, Sleepio, is a digital sleep improvement program featuring personalized Cognitive Behavioral Therapy (CBT) techniques, delivered by virtual animated sleep expert The Prof and his narcoleptic dog Pavlov. In the world’s first placebo-controlled randomised trial for an intervention of its kind, Sleepio was shown to be comparable in effectiveness to face-to-face therapy.
Follow Peter Hames:
About Big Health, Lucky Voice, NHS England, Sleepio: Big Health is a digital therapeutics company operating a healthcare portal to offer behavioral programs for mental health issues.
Steve Cahillane
President & Chief Executive Officer of NBTY
Steve Cahillane joined NBTY in September 2014 as President & CEO. Since that time, he has also served as a member of the Board of Directors of NBTY. Prior to joining NBTY, Steve served as President of Coca-Cola Americas, which consists of both the North American and Latin American operations. Before assuming that role, he held positions as President and CEO of Coca-Cola Refreshments (CCR), an operating unit of the North American business of The Coca Cola Company, and President of Coca-Cola Enterprise’s (CCE) North American business. Mr. Steven A. Cahillane, also known as Steve, has been the Chief Executive Officer and President at Kellogg Company since October 2, 2017 and has been its Chairman since March 16, 2018. Mr. Cahillane possesses particular knowledge and experience in a variety of areas, including accounting and financial acumen, risk management, innovation and research and development, branded consumer products and consumer dynamics, regulatory and government that strengthens the Board’s
Follow Steve Cahillane:
About Kellogg’s, NBTY: NBTY is a leading global vertically integrated manufacturer, marketer and distributor.
Alex Blyth
CEO of LIfT BioSciences
Serial entrepreneur with 15 years’ experience in commercialising biopharma assets and strategy consulting, having advised teams and led the strategic planning on the launch of over 50 assets. Founded the company after losing his mother to Pancreatic Cancer.
Follow Alex Blyth:
About LIfT BioSciences, NGX: LIfT BioSciences is a socially-minded Biotech start-up that develops a portfolio of potentially life-saving immuno-oncology cell therapies.
Mayank Banerjee
Co-Founder and CEO of Even
Mayank Banerjee joined Even Healthcare as Co-Founder in 2020.
Follow Mayank Banerjee:
About Even: Even is a health-tech company and healthcare provider that partners directly with the top hospitals in the country.
George Goldsmith
Executive Chairman, Chief Executive Officer & Co-Founder of COMPASS Pathways
George is a serial entrepreneur with significant experience in pharmaceutical regulation. George’s early training and experience was a multi-disciplinary blending of cognitive psychology, clinical psychology and computer science.His first company, The Human Interface Group, was a pioneer in collaborative software and acquired by Lotus Development. George led the Lotus Institute and developed software and services to support high-performance, distributed teamwork. George then created TomorrowLab, which provided strategic guidance to internet businesses in the late 1990s. At the same time, he became a senior advisor to McKinsey & Company’s leadership, and eventually joined McKinsey as CEO of TomorrowLab@McKinsey. Subsequently, as a member of the Young Presidents Organisation (YPO) and its International Board of Directors, George founded YPO Networks. In 2002, George founded Tapestry Networks, an organisation committed to improving leadership performance and governance effectiveness in regulated sectors. He still serves as Tapestry Networks’ Non-Executive Chairman. George also serves on the board of directors for AnaBios, a company redefining drug discovery. He and his wife, Ekaterina Malievskaia MD, live in London.
Follow George Goldsmith:
About COMPASS Pathways: Compass Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health.
John M. Foraker
Co- Founder & CEO of Once Upon a Farm
John Foraker is the Co- Founder & CEO at Once Upon a Farm .
Follow John M. Foraker:
About Once Upon a Farm: Once Upon a Farm creates quality, eco-friendly, and nutritious food products for children.
Avi Lasarow
CEO Europe, Middle East & Africa of Prenetics
Avi Lasarow is a multiple award-winning South African entrepreneur referred to by the media as ‘a lifestyle genetics pioneer’ known for his work associated with DNA testing. Avi is currently founder and CEO of genetic testing company DNAFit Life Sciences, which conducted the worlds 1st peer-reviewed and published clinical trial using both genetics and exercise interventions. In 2011 he became the youngest person to be appointed Honorary Consul for South Africa to the United Kingdom by His Excellency President Jacob Zuma. Avi was recently named African Businessman of the year in London at the African Enterprise Awards, his company DNAFit has won numerous awards, including the Lloyd’s Bank National Business Award for Innovation of the Year in 2015, winner at the UKActive Flame Awards and an award for Innovation at the South African Chamber Awards. Most recently, DNAFit was named as one of Fast Company’s Most Innovative in the field of Data Science.
Follow Avi Lasarow:
About DNAFit, Prenetics: Prenetics is a genetic and diagnostic health testing company that helps identify health risks with the use of a DNA sequencing technology.
Pal Erik Sjatil
Global Managing Partner and CEO of Lightrock
Pal Erik Sjatil is the Global Managing Partner and CEO at Lightrock, a global private equity partnership that seeks to achieve financial as well as societal and environmental returns. Lightrock invests in sustainable businesses built by purpose-driven entrepreneurs committed to innovation for systemic change at scale. The company has one of the largest impact-focused growth portfolios in Europe, Latin America and India. More recently, Lightrock has also started building out a portfolio of investments across Sub-Saharan Africa. It invests in companies that pursue scalable and technology-driven business models around the themes people, planet and productivity/tech for good. Specific investment sectors within these themes include education, healthcare, access to finance, mobility, transportation, renewables and circular-economy transition. Lightrock investments demonstrably contribute to the United Nation’s Sustainable Development Goals. Lightrock’s portfolio currently encompasses more than 70 high-growth companies, including Infarm, one of the world’s fastest growing urban farming networks with more than 1200 farms installed; PharmEasy, one of the largest omni-channel healthcare platforms in India; DrConsulta, one of the largest healthcare chains in Latin America; and M-Kopa, a global pioneer for pay-as-you-go solar energy services for off-grid customers in rural East Africa. In 2019, CMR Surgical, a developer of surgical robots that will broaden access to keyhole surgery, was the first of Lightrock’s portfolio companies to become a unicorn – followed by several others, such as Lilium, the sustainable aviation company. As an active owner, Lightrock supports its portfolio companies from a board position in their dynamic growth and expansion phase. Prior to joining Lightrock, Pal Erik Sjatil was a Senior Partner at McKinsey & Company, a member of the firm’s Shareholders Council, and the Managing Partner of McKinsey’s offices in Europe. Before assuming that role, he led McKinsey’s office in Norway, was part of the leadership of the Scandinavian offices, led the office complex in Eastern Europe, and was the Managing Partner of McKinsey’s offices in EEMA (Eastern Europe, Russia/CIS, Turkey, the Middle East, and Africa). Pal Erik also held leadership roles in the firm’s Telecommunications, High Tech, and Strategy & Corporate Finance practices. At McKinsey, he served clients in the telecom, high tech, financial services, and oil and gas industries and focused on corporate strategy, operations, and organizational transformations.
Follow Pal Erik Sjatil:
About Lightrock: Lightrock is a global private equity platform that backs purpose-driven entrepreneurs tackling the world’s biggest challenges.
George Pallis
Co-Founder & CEO of Manual
George Pallis is the Co-Founder and Chief Executive Officer of Manual.
Follow George Pallis:
About Manual: Manual provides diagnostic tools and testing to help patients make health-related decisions.
Peter Ward
CEO and Co-Founder of Humanity
Peter Ward is a Co-Founder and Chief Executive Officer at Humanity.
Follow Peter Ward:
About Humanity: Humanity is a healthcare company that aims to extend the healthspan of humanity.
Adnan Ebrahim
Co-founder & CEO of MindLabs
Co-founder & CEO of MindLabs. Previously Founder & CEO of Car Throttle (acquired by Dennis Publishing in 2019). Forbes 30 Under 30 2020.
Follow Adnan Ebrahim:
About MindLabs: MindLabs is the world’s first live mental health platform.
Frank Hester OBE
Founder & CEO of The Phoenix Partnership
Frank has always been at the forefront of IT innovation. In his early career he was instrumental in building technological infrastructure in the finance industry. Frank founded TPP in 1997 and pioneered integrated care – delivering his vision of connected care across all health settings. Today, TPP provides leading software that is transforming healthcare worldwide. Frank is active in all aspects of the company’s business operations, working alongside the teams in the development of TPP’s products and representing the company in the public domain. Frank’s innovative vision is nationally recognised by the NHS, leading journals and healthcare organisations. In 2012, he was elected to the board of TechUK as a spokesperson for the healthcare IT sector. The following year, he was listed as one of the UK’s top 50 innovators in the national health publication, HSJ. In 2015, Frank was named on the Queen’s New Year’s Honours List to be awarded with an OBE (Order of the British Empire), for his services to healthcare. Frank has been invited on numerous government trade missions, representing the UK health industry around the world. He has visited countries such as China, India and Brazil as part of trade missions led by British Prime Minister, David Cameron and by Kenneth Clarke, QC, MP.
Follow Frank Hester OBE:
About The Phoenix Partnership: TPP is a healthcare technology company, dedicated to delivering world class healthcare software in the UK and internationally.
Max Parmentier
Co-Founder & CEO of Birdie
Max Parmentier is the Co-Founder and Chief Executive Officer of Birdie.
Follow Max Parmentier:
About Birdie: Birdie is a digital caretech company focused on elderly care at home.
Matt McCambridge
Co-Founder and CEO of Eden Health
Matt McCambridge is the Co-Founder and CEO at Eden Health.
Follow Matt McCambridge:
About Eden Health: Eden Health is a primary care and insurance navigation company for employers seeking to elevate the health and wellbeing of their employees.
Martin Blinder
Founder and CEO of Tictrac
Martin is an Internet and Digital Health entrepreneur with a focus on consumer web. He is co-founder and CEO of Tictrac, a leading Connected Health platform that engages people in their health, through their data. Tictrac is at the forefront of the consumerization of healthcare, centralizing an otherwise fragmented sector around the consumer, under the credo: consumer engagement is the key to better health outcomes. Tictrac won Best New Company at Health 2.0 in 2012. Martin was named among the 15 most influential in Digital Health, and has been featured in Wired, NYT, BBC, CNBC, Fortune, Mashable, Wall Street Journal, among others. He is also an active member of YPO, London chapter. Prior to Tictrac, Martin cofounded one of the first online financial services sites in Europe and has advised Prime Ministers and other state officials on innovation, foreign direct investment and entrepreneurship.
Follow Martin Blinder:
About Tictrac: Tictrac is a connected health platform that engages people in their health through their data.
Stephan Tual
Founder, CEO of 3 Billion Pairs Genetic
Stephan Tual is the Founder & CEO at 3 Billion Pairs Genetics Ltd. & he attended Institut Franco-Américain de Management in 1995.
Follow Stephan Tual:
About 3 Billion Pairs Genetic: 3 Billion Pairs Genetic is a biotechnology based company.
Dipankar Bhattacharjee
President & CEO: Generics Europe of Teva Pharmaceutical Industries
Mr. Dipankar Bhattacharjee was appointed President and CEO, Generics Europe in April 2013. Mr. Bhattacharjee joined Teva as Chief Executive Officer, Teva UK Limited in 2009. Prior to joining Teva, he served 15 years at Bausch + Lomb in various senior roles, including Vice President, Commercial in both Europe and Asia-Pacific regions, and Corporate Vice President and President, Asia Pacific Region. Mr. Bhattacharjee began his career at Nestlé SA and Bank of America. Mr. Bhattacharjee received a BA in Economics from St. Stephens College, University of Delhi, and a Masters degree in Management Studies from Jamnalal Bajaj Institute of Management Studies, University of Mumbai.
Follow Dipankar Bhattacharjee:
About Teva Pharmaceutical Industries: Teva Pharmaceutical Industries is a pharmaceutical company specializing in the development, production and marketing of generic.
Connor Campbell
Founder and CEO of Osler Diagnostics
Follow Connor Campbell:
About Osler Diagnostics: Lab-quality diagnostics for anyone, anywhere, at any time.
Gregg Sando
Founder & former Chief Executive Officer of Kuur Therapeutics
Gregg Sando is the founder and CEO of Cell Medica. After a career in investment banking based both in London and New York, he completed his Immunology MSc degree at the medical school of Imperial College. Recognizing the significant progress taking place in the field of cellular immunotherapy, Gregg formed Cell Medica in cooperation with a small group of the leading clinicians and immunologists who were pioneering this new mode of medical treatment. (B.A. Biochemistry, Harvard University; M.B.A. University of Chicago; MSc Immunology, Imperial College London).
Follow Gregg Sando:
About Kuur Therapeutics: Kuur Therapeutics is committed to transforming the lives of patients with cancer & is leading the development cell therapies.
Sunny Ahonsi
CEO of MediLiVes
Experienced algorithmic crypto trader and a healthcare evangelist. Mr. Sunny Ahonsi (MBA, BA, FCCA, FOTHM, ACILT, ACIS, ACEA, MCIM, MIVA, DIPM) a professional-trained accountant and a member of The British Blockchain Association, has led highly regarded organizations across the globe for years by providing innovative and development solutions to corporate and governmental organizations. He has managed several startups and helped SMEs in securing and raising finance to accelerate the growth of their business.
Follow Sunny Ahonsi:
About MediLiVes: Uberization of Healthcare & Telemedicine. Join the innovative AI based telemedicine system.
Matteo Berlucchi
CEO & Co-Founder of Healthily by Your.MD
Matteo’s digital career spans 20 years, during which he has conceived, built and launched several successful companies and services both online and on mobile. Most recently, Matteo was Chief Digital Officer at Northern & Shell, the largest independent media company in the UK,where he grew traffic and revenues 4-fold in just 12 months. Matteo was also the founder and CEO of aNobii, the ebook platform funded by Penguin Random House, HarperCollins which was acquired by Sainsbury’s in 2012. Matteo founded Livestation, the leading service for live TV news online and the first company in the world to stream live TV on iPhones. Livestation is also the winner of the Guardian Digital Innovation Award 2008. Prior to this, Matteo was CEO and co-founder of Skinkers, a software company, which defined the market for desktop widgets and the winner of several international innovation awards in the digital space. Matteo started his career by launching the first online property system in Europe in 1995.
Follow Matteo Berlucchi:
About Healthily by Your.MD, Vini Italiani: Healthily is the world’s first medically approved self-care app designed around you.
Tom Simmons
Founder & CEO of Supplant
Tom has over 10 years of experience in carbohydrate biochemistry. He formerly held fellowships at the University of Cambridge and at the World Economic Forum and has advocated sugar reduction initiatives through Sky News and Channel 4 television appearances.
Follow Tom Simmons:
About Cambridge Judge Business School, Supplant: Supplant is a biotechnology platform that makes sugar substitutes.
Jan Spaticchia
Chairman & CEO of Energie Group
Jan Spaticchia is the Founder and Chairman at Empowered Brands.
Follow Jan Spaticchia:
About Be Military Fit, Empowered Brands, Energie Group, Hedgehog Concept: Energie is genuinely like no other fitness club group.
Mark Livingstone
Chief Executive Officer of Pharmacy2U
Mark became Pharmacy2U’s CEO following a merger with ChemistDirect.co.uk in July 2016. An entrepreneurial business leader who has held many senior positions across retail and technology. Roles include co-founder and CEO of LOVEFiLM, worldwide Managing Director of Lego Interactive and one of the people behind the startup, Graze.com. With a passion for understanding how things work, Mark is a keen engineer who has rebuilt three 1950s Austin-Healeys.
Follow Mark Livingstone:
About ChemistDirect, Pharmacy2U: Pharmacy2U are the UK’s leading NHS approved online pharmacy and also provide a confidential private online doctor service.
David Plans
CEO and Co-Founder of BioBeats
David Plans is a member of the University of Surrey’s Center for Digital Economy and Center for Vision, Speech and Signal Processing, and is working towards machine learning solutions to foster human wellbeing. His primary research focus is adaptive media and affective modelling. Having worked on early mHealth projects in the NHS, he is now leading smartphone and wearable research projects at BUPA, AXA/PPP, and Microsoft Health with his startup, BioBeats, where they are helping actuarial and care provision teams think differently about preventative health.
Follow David Plans:
About BioBeats: BioBeats is a human company that creates digital artificial intelligence products to tackle mental health globally.
Emil Hewage
Co-Founder & CEO of BIOS
Emil’s academic background is as a PhD researcher in computational neuroscience and machine learning. He brings knowledge of neural signalling and signal processing with over 7 year’s industrial & academic R&D experience. He has previously developed medical devices with Siemens Healthcare and Sphere Medical as well as having held roles in finance and medical and cleantech startups.
Follow Emil Hewage:
About BIOS: A full-stack neural interface platform, that uses AI to decode and encode the signals from to the body, to treat chronic health conditions.
Sandeep Bansal
Founder & CEO of Medic Creations
Dr Bansal graduated from Imperial College London with a MSc in Paediatrics and Child Health. In 2013 he started his General Practitioner training at Oxford Deanery where he was also Trainee Lead, representing Oxford Deanery for the Associates in Training (AiT) committee in their quarterly meetings at Royal College of General Practitioners. From his professional experience and feedback from his peers, DrBansal raised the concerns of poor Information Governance (IG) compliance around sharing patient dataat AiT meetings. With the AiT board’s response of their inability to offer an alternative solution, Dr Bansalcarried out a survey to understand the extent of the problem in 2014. The survey for his 180 colleagues went viral and he received 2050 responses confirming the poor IG compliance practice, predominantly around the use of WhatsApp. In 2014 he set up Medic Creations and created the innovative app MedicBleep to enable secure and reliable clinical communication for primary, secondary and community care. With enabling communication across healthcare organisations and professionals, Medic Bleep empowerstrue interoperability, the future of healthcare management and innovation. Medic Creations was selected for Web Summit Alpha 2015 and is listed in the Journal of mHealth’s top100 Global Digital Companies for 2016 and 2017.
Follow Sandeep Bansal:
About Bennett Coleman and Co Ltd, Harvard Medical School, Medic Creations, shl.vc: Revolutionising Communications in Healthcare
Mark Kotter
Founder/CEO of bit.bio
Mark Kotter is the founder and CEO of bit.bio.
Follow Mark Kotter:
About bit.bio: Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.
Mike Moran
Chief Executive Officer of Rutherford Health
Mike Moran MBE is a founder of the company and has 30 years of experience in strategic leadership, planning and programme delivery. He has held various executive positions in defence and healthcare in the UK and abroad and is the Former Chairman of the Chamber of Commerce & Learning & Skills Council in Hereford and Worcestershire.
Follow Mike Moran:
About Rutherford Health: Rutherford Health is provides proton beam therapy/radiotherapy services for cancer treatment.
Damian Milkins
Chief Executive Officer of Amplify Life
Follow Damian Milkins:
About Amplify Life: Amplify Life is an app that provides coaching for fitness and wellbeing.
Chris Edson
Co-founder & CEO of Second Nature
Christopher Edson CEO & Founder of EU Top 50 Startup, Forbes 30 Under 30
Follow Chris Edson:
About Second Nature: Second Nature is a digital programme that helps people lead healthier lives
Dan Vahdat
Co-founder & CEO of Huma Therapeutics
Dan Vahdat is Co-founder & CEO of Medopad, a British healthcare technology company enabling connected care, headquartered in London, UK. Dan is an award winning innovator in the fields of science and technology. His professional career spans from IT to medical technology including several years at Johns Hopkins in the US. Dan studied Engineering and Mathematics, after which he pursued his PhD in at Johns Hopkins including 2 years of abroad study at Oxford University. Before finishing his degree, he left to focus on his business.
Follow Dan Vahdat:
About Huma Therapeutics: Huma provides a digital health platform used for predictive care and research.
Nader Alaghband
Co-Founder & CEO of Ampersand Health
Follow Nader Alaghband:
About Ampersand Health: Ampersand creates innovative digital medicines for complex long term conditions, using behavioural and data-science.
David MacMurchy
Chief Executive Officer of Lightship
David MacMurchy is the Chief Executive Officer at Lightship.
Follow David MacMurchy:
About Lightship: Lightship is a provider of enterprise-level and direct-to-patient clinical research solutions for decentralized clinical trials.
Jonathan Relph
Founder & CEO of VITL
Follow Jonathan Relph:
About VITL: On a mission to make healthy living more achievable, providing beautifully designed, expertly researched nutritional products and content.
Sam Cole
Co-Founder and CEO of FitXR
Sam draws on his experience from consulting and private equity to drive FitXR forward into the uncharted lands of fit tech. Coming from a family of entrepreneurs, Sam was always enchanted by the prospect of building a company. Meeting Sameer at business school kick-started that dream. A lover of all things fitness, Sam is excited to develop a product that will help people access professional workouts, and build healthier communities around the world.
Follow Sam Cole:
About FitXR: FitXR, the leading developer of VR/AR fitness apps, is passionately dedicated to making fitness more fun and accessible for everyone.
Abdullah Albeyatti
CEO & Co-Founder of Medicalchain
Dr Albeyatti graduated from Imperial College London as a doctor in 2011. He has always had a passion for innovation and problem solving and has developed solutions to inefficiencies he found whilst working in the UK National Health Service. In 2016 he co-founded Medicalchain, initially as Discharge Summary – an application used in hospitals to generate accurate medical reports on patients, before they are discharged. Dr Albeyatti’s career in medicine started with surgical training in London and has moved on to general practice with a view to continuing his ENT passion and furthering his management aspirations. He continues to work in Accident and Emergency to sharpen his clinical skill set.
Follow Abdullah Albeyatti:
About dischargesummary.co.uk, Medicalchain, MyClinic, NHS, NHS England: Medicalchain is a decentralized platform that enables secure, fast and transparent exchange and usage of medical data.
Aron Rachamim
Founder & CEO of Senzo
Aron Rachamim is committed to changing the world by putting healthcare information into everyone’s hands. A serial entrepreneur, scientist, and experienced leader, Aron aims to apply pioneering technologies to improve people’s quality of life. His expertise and passion for the science of microfluidics builds on his background in life sciences, physics, and engineering. His company Orphidia intends to transform the world of medical diagnostics. Aron launched Orphidia in 2013 to provide affordable, point-of-care diagnostics that allow everyone to know their health. Orphidia has advanced the state-of-the-art with microfluidic-based medical diagnostics that are minimally invasive, replacing venous blood draws from a phlebotomist with a simple fingerstick that anyone can perform. Aron is a serial entrepreneur, whose background combines a PhD from the University of Cambridge and a focus on microfluidics and biotechnology with strong experience in professional management. At Protein Logic, a spin-out from Cambridge University that raised more than £3 million in initial funding to develop proprietary biomarker technology for the diagnosis and prediction of diseases, he served as COO. At WiseMed, where he was Co-founder, his team developed crowdsourced medical diagnostic technology as an affordable solution for improving healthcare in the developing world. Now, at Orphidia, Aron is providing the vision and leadership that will usher in the next generation of medical diagnostics, empowering everyone to know their health.
Follow Aron Rachamim:
About Senzo: Senzo is a deep-tech bio-med company developing testing products and IP.
Melinda Nicci
Founder and CEO of Baby2Body
Melinda is founder and CEO of Body Collective (Baby2body) the award- winning, wellness company for women.
She is a Sports and Exercise Psychologist, author of two bestselling books, is a regular contributor on the BBC, and sits on numerous boards as a NED, including The ICE List and Team GB (Olympic and Para-olympics snow-sport teams).
Melinda was named the UKBAA High Growth Founder of the year 2019/20, and has won numerous accolades and awards for entrepreneurship, including being named in the UK list of the Most Influential Women in Tech for 4 years running.
A serial entrepreneur, she founded and sold her first business at the age of 25 in South Africa, and held the position of Senior Director for Consumer health Innovation at Philips in Amsterdam. Melinda brings her passion for sport, performance and wellness to the numerous companies she advises and has created a global business with Body Collective, helping millions of women all over the world to live healthier and happier lives.
Follow Melinda Nicci:
About Baby2Body, GB Snowsport, ICE List: Baby2Body is a fully automated health, fitness and wellbeing coaching platform for pregnant women and mothers.
Emi Gal
Co-founder & CEO of Ezra AI
Emi Gal is a co-founder of Brainient, a video advertising technology company. Prior to launching the startup in 2009, Gal started two other companies and was involved with various technology and internet startups, including Skimlinks (UK), eOk (Romania) and SkinScan (Romania). Gal occasionally speaks at various entrepreneurship and technology events, writes for The Telegraph and TechCrunch Europe, and has a strong interest in technology and education. He is also a board director on the Board of Romanian seed fund, Digital Catalyst Fund. He has been named in Forbes Romania Top 30 Under 30 (2012) and SquareMile Magazine’s Top 30 Under 30 (2011), and was the Seedcamp winner in 2009. Gal loves experiments, tennis, swimming, books and chocolate.
Follow Emi Gal:
About Ezra AI, Zeno Wearables: Ezra AI provides early cancer detection by combining advanced medical imaging technology and AI technology.
Anne Prener
President & CEO of Imbria Pharmaceuticals
Anne brings to Freeline over 25 years of experience in drug development and executive leadership across several therapeutic areas, with special focus on rare diseases and gene therapy. Anne most recently served as the CEO of Gyroscope Therapeutics, a preclinical gene therapy company focusing on ophthalmology, where she continues to serve as a non-executive Member of the Board. From 2014-2016, Anne was VP of Clinical Research Haematology and Global Therapeutic Area Head of Haematology in Baxalta, Boston, USA. In this role, she secured several new product approvals (US and EU). Before this, Anne held a number of senior leadership positions in a broad range of functional areas at Novo Nordisk, Denmark, leading global drug development programmes from research to commercialisation, and bringing several products to market globally. Anne has an MD from Copenhagen University and holds a PhD in Epidemiology.
Follow Anne Prener:
About Imbria Pharmaceuticals, Kaleido BioSciences: Imbria Pharmaceuticals is a biotechnology company with locations in San Diego, CA, and Boston, MA.
Sokratis Papafloratos
CEO of Numan
Sokratis Papafloratos works as a Founder and CEO at Togethera. Previously CEO & co-founder of TrustedPlaces, acquired by Yell Group in 2010. Engineering degree from York University.
Follow Sokratis Papafloratos:
About Numan, TrustedPlaces: Numan: Helping Your Health Wherever We Can
Guy Blomfield
Chief Executive Officer of Alliance Medical
Guy was appointed Chief Executive Officer of Alliance Medical Group in June 2012 having joined Alliance Medical as Group Chief Operating Officer in 2011. Prior to Alliance Medical, Guy spent four years on the board of General Healthcare Group as Commercial and Strategy Director. Previous to GHG, Guy was on the board of Oasis Healthcare which was successfully sold to Duke Street Capital in 2007. Guy has also held a number of management consultancy roles, including as owner and Managing Director of Imcis Ltd, a specialist strategy consultancy with expertise in pubs, franchise operations, apparel and food retailing. Guy holds a degree in Accounting and Finance and he has an MSc in Corporate Finance.
Follow Guy Blomfield:
About Alliance Medical: Alliance Medical is independent provider of imaging services.
Rayna Patel
Co-Founder and CEO of Vinehealth
Rayna is a medical doctor and neuroscientist with over a decade of experience in healthcare, working in frontline hospitals, national government policy and clinical research (Cambridge, UCL, Harvard, MIT and Columbia). She held strategic and commercial roles in tech startups, government policy and the Cabinet Office’s Nudge Unit, where she used behavioural neuropsychology to change patient behaviours through commercial products.
Follow Rayna Patel:
About Vinehealth: Vinehealth is a AI-driven platform providing support to improve the quality of life and survival of cancer patients.
Khoa Phan
CEO & Co-Founder of Backbone Labs, Inc.
Khoa’s entrepreneurial spirit and engineering experience drives the strategic vision of Backbone Labs, as well as the development of its products. Before he launched Backbone Labs, Khoa founded a successful marketing agency specializing in search, content and social media ad campaigns for acquiring customers and users. He has also co-founded an indie mobile game studio. When he’s not building companies, Khoa is an avid collector of rare sneakers.
Follow Khoa Phan:
About Backbone Labs, Inc.: Identify at-risk behavior in the workplace and recommend actions to promote and maintain overall back-related wellness.
Dr Margaret Temple
CEO of Vitrology
Margaret Temple is a science and business graduate of Edinburgh University who joined the biotechnology industry in 1995. Following several commercial roles with Q- One Biotech Limited Margaret was appointed as a Board Director in 2002. In 2007 Margaret co -founded Vitrology Limited having secured funding from Archangels, and was appointed CEO in 2009. Vitrology was acquired by the Swiss multinational SGS in 2012, and a two year period of integration was completed at the end of 2014.
Follow Dr Margaret Temple:
About Vitrology: Vitrology is a biopharmaceutical contract testing organization in the biosafety testing sector of the pharmaceutical industry.
John E. Milad
CEO & Founder of Quanta
John E. Milad is a global healthcare executive, board member, investor, speaker and author. He has a career spanning over 25 years, with experience working in various senior positions in the healthcare sector, including NBGI Ventures, Atlas Venture, Nitec Pharma and Nomura. Currently, John is Chief Executive Officer and founding board member at Quanta Dialysis Technologies, where he recently raised $245m in Series D funding. An executive with international experience in building and growing successful healthcare companies, John had the vision and belief that core technology of managing fluidics on a disposable cartridge could be developed into a portable hemodialysis device with the potential to address multiple unmet needs in the $93 billion global dialysis market. John is a regular speaker and panelist at global medtech and investment conferences and has co-authored 4 peer-reviewed papers.
Follow John E. Milad:
About NBGI Ventures, Quanta: Quanta develops an advanced haemodialysis systems for use in the home and clinic.
Abdullah Sabyah
Founder and CEO of Rightangled
A scientist-entrepreneur and a healthcare professional, also a member of the British Heart Foundation Alliance, a member of the Clinical Pharmacogenomics Implementation Consortium in the US, and the inventor of a patent pending-technology for nucleic acid testing on a lateral flow assay (the patent is for a technology to detect DNA sequences in real-time).
Follow Abdullah Sabyah:
About Rightangled: Medtech specialised in Genetics, Blood and infection testing. Service is delivers through a platform that connects users with specialists.
Ali Rezaei Haddad
CEO and Founder of NeuroNav
Ali is a neurosurgical resident in London and an NHS Clinical Entrepreneur. Prior to this, he completed his Academic Foundation Training in the Medical Sciences Division at the University of Oxford undertaking research in the field of neuroimaging. He graduated with first class honours in Neurosciences BSc at Imperial College London, and he holds honorary research positions at the University of Oxford and St George’s Medical School. Ali co-founded the internationally acclaimed GoodSAM app used by the NHS, in which clinically trained individuals sign up as volunteers to respond to life-threatening emergency calls. He also directed and curated the Imagining the Future of Medicine at the Royal Albert Hall in partnership with TEDMED, attended by a live audience of 5,000 people. Inspired by the lack of user friendly and affordable neuronavigation solutions worldwide, he founded NeuroNav to democratise access to neurosurgery navigation solutions.
Follow Ali Rezaei Haddad:
About Imperial College Healthcare NHS Trust, NeuroNav: An augmented reality neuronavigation platform powered by computer vision and machine learning.
Nick Taylor
Co-Founder and CEO of Unmind
Follow Nick Taylor:
About Unmind: Unmind is a B2B mental health platform providing clinically-backed tools and training.
Nick von Christierson
CEO & Co-Founder of Woven Science
Nick von Christierson is the CEO and Co-Founder at Woven Science.
Follow Nick von Christierson:
About Baby Bundle, Woven Science: Woven Science backs and builds best-in-class companies in the mental wellness space with a focus on psychedelic therapeutics.
Melissa Morris
CEO of Lantum
Follow Melissa Morris:
About Lantum: Lantum is the online platform that enables healthcare providers to manage their clinical workforce.
Sina Habibi
CEO of Cognetivity Neurosciences
Sina Habibi is the CEO at Cognetivity Neurosciences.
Follow Sina Habibi:
About Cognetivity Neurosciences: Cognetivity Neurosciences is a Platform technology for early, rapid and easy detection of dementia.
Chas Taylor
Chief Executive Officer & Chairman of Respiratory Motion
Mr. Taylor has over 30 years of experience in the medical technology industry. Recently he was the CEO of Veryan Medical, a Co-founder and Director of Novate Medical, and a Director of BrightWater Medical. All three of these companies were acquired in the last three years. Previously, Mr. Taylor was the Co-founder of MedNova, which was acquired by Abbott Laboratories. Prior to founding and leading these companies, he had a long career with Bard Cardiovascular and General Surgical products where he had roles of increasing responsibility in general management and international sales and marketing.
Follow Chas Taylor:
About : Respiratory Motion ExSpiron is FDA and CE Mark cleared and non-invasively measures minute ventilation, the fundamental unit of breathing.
Mario Alberto Accardi
CEO and Co-Founder of Orexia
Life sciences executive and investor focused on starting, funding and running companies in the life sciences. Over a decade experience in the industry spanning fundamental research, venture capital and operational roles. I am now CEO and Co-Founder of Orexia and Inexia, two biotech companies founded with VC investor Medicxi and Sosei Heptares. I am also CEO and Co-Founder and inventor behind Orthonika, a medtech spin-out from Imperial College London.
Follow Mario Alberto Accardi:
About Orexia, Orthonika: Orexia aims to develop orally administered orexin positive modulators for the treatment of neurological diseases.
Carina Cunha
Co-Founder & CEO of Be Nosy
Carina is a business strategist and inventor of Nosy with passion for science, sales and marketing. In her former role as MD and Launcher of Crimson Education Europe, she created sales, marketing and service delivery teams from scratch, achieving millions in ARR and 150%+ YoY growth. Prior to working with startups Carina was corporate strategist at JPMorgan, Strategy Consultant at Accenture, Investment Banker at Credit Suisse, and a fashion model with Elite. Carina is also an innovation and commercial consultant through Meta Strategy and Founders Intelligence where she helps startups and scale-ups find product-market fit and corporates build new revenue lines. She has a B.A. from Columbia University and PgD. from the University of Edinburgh.
Follow Carina Cunha:
About Be Nosy: Nosy is a MedTech startup developing wearable air filter and air pollution tracking network.
Quintus Liu
Chairman & CEO of Healthera
Quintus is a professional healthcare entrepreneur and investor who ideated the concept of patient-centric digital care known as Healthera.
Follow Quintus Liu:
About Healthera: Transforming the way a nation delivers its healthcare to its population, from prescriptions to personalised services.
Charles Wells
Founder & CEO of HelloSelf
Follow Charles Wells:
About Braintech, HelloSelf: HelloSelf is a health and wellness platform that provides its users with digital access to therapists.
Bobby Gaspar
Chief Executive Officer of Orchard Therapeutics
Bobby is Professor of paediatrics and immunology at the UCL Institute of Child Health and Honorary Consultant in paediatric immunology at Great Ormond Street Hospital, London. He has a special interest in the treatment of severe primary immune deficiencies, including bone marrow transplantation, gene and cell therapy. He has led multiple clinical trials that have shown that gene therapy can successfully correct the genetic defect in immune deficiencies. Bobby is currently leading UK and European-wide initiatives for newborn screening in severe combined immune deficiency. He is Director of the Centre for Research in Rare Diseases in Children (CRRDC), a new academic and clinical facility that will open at Great Ormond Street in 2018.
Follow Bobby Gaspar:
About Orchard Therapeutics: Orchard Therapeutics is a biotechnology company dedicated to transforming the lives of patients through innovative gene therapies.
Ali Parsa
Founder and CEO of Babylon
Ali is an entrepreneur and engineer. He built Circle to become Europe’s largest partnership of clinicians, achieving around £200M in annual revenue, 3000 employees and a successful IPO, all during an economic recession. He was named by The Times as among the 100 global people to watch, and was the recipient of the Royal Award for young entrepreneurs for founding V&G earlier in his career. Ali is a UK Cabinet Office Ambassador and has a PhD in engineering Physics.
Follow Ali Parsa:
About Babylon: Babylon is a world leading, digital-first, value-based care company.
Zhangming Niu
Founder & CEO of MindRank AI
Follow Zhangming Niu:
About MindRank AI: MindRank is a developer of an AI-enabled drug-discovery platform intended to discover and develop next generation precision medicines.
James Noble
Founder & CEO of Adaptimmune
James Noble has served as our full-time Chief Executive Officer since March 2014 and part-time CEO from July 2008 to March 2014 and is one of our co-founders. From July 2008 until March 2014, Mr. Noble was also part-time CEO of Immunocore. Mr. Noble has 24 years of experience in the biotech industry. He has held numerous non-executive director positions, including at CuraGen Corporation, PowderJect Pharmaceuticals plc, Oxford GlycoSciences plc, MediGene AG, and Advanced Medical Solutions plc. Mr. Noble is also Deputy Chairman of GW Pharmaceuticals plc and a non-executive director of Immunocore Limited. Mr. Noble is qualified as a chartered accountant with Pricewaterhouse Coopers and spent seven years at the investment bank Kleinwort Benson Limited, where he became a director in 1990. He then joined British Biotech plc as Chief Financial Officer from 1990 to 1997. Mr. Noble was previously Chief Executive Officer of Avidex Limited, a privately held biotechnology company that was our predecessor, from 2000 to 2006. Mr. Noble holds an MA from the University of Oxford.
Follow James Noble:
About Adaptimmune, Advanced Medical Solutions, Curagen Corporation, MediGene, Oxford GlycoSciences, PowderJect Pharmaceuticals: Adaptimmune develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.
Dennis O’Brien
CEO of Lucid Group Communications
Role To lead our team to be the best we can be and to make a difference to patients through healthcare. Pharmacology graduate. 13 years in pharma in a variety of roles. Co- founded Lucid in 2007 based on a passion to help pharma improve education to healthcare professionals. Background Favourite part of the job Helping to shape our future. Seeing and rewarding progress in line with our vision.
Follow Dennis O’Brien:
About Lucid Group Communications: Lucid offer talented writers an exclusive, tailor-made package to suit their individual needs and desires.
Soumyadip Rakshit
Co-Founder & CEO of MysteryVibe
Soumyadip is a serial entrepreneur and Co-Founder of sex-tech company MysteryVibe . His mission is to apply Intelligence of Things to the world of Pleasure and create and immersive experience to transform bedrooms into sensual sanctuaries. The mission is gaining pace. MysteryVibe won the consumer product design category at the Design Week awards, beating the Apple Watch. Last year, it closed a funding round worth $1.5 million (£1.1 million) bringing the total raised by the company to over $4 million in three years and valuing it at $13 million. The sex-tech market, which is estimated to be worth $15 billion, has so far had very little outside investment. Rakshit says: “There’s huge potential, and that’s helped investors get over their initial reservations about the sector.” He still loves the moment at tech conferences when he starts talking about sex and pleasure and people’s expressions turn from smiles and giggles to curiosity and seriousness.
Follow Soumyadip Rakshit:
About MysteryVibe: Award Winning Sexual Health Products. Deeply researched, anatomically designed, doctor-endorsed products to make intimacy easy.
Hamish Grierson
CEO & Co-Founder of Thriva
Hamish Grierson is the CEO and co-founder of Thriva.
Follow Hamish Grierson:
About Thriva: Thriva offers a personalized at-home finger-prick blood test which enables individuals to easily track and improve health.
Tamara Rajah
Founder & CEO of Live Better With
A couple of years ago, Tamara got really frustrated from her professional and personal experiences. She found that there are so many things that could help people living with cancer live better day-to-day, but they don’t know about them or don’t know where to buy them. She left her job in healthcare and set up Live Better With to change that.
Follow Tamara Rajah:
About Live Better With: Make life a little bit better with 100s of recommended products for people living with cancer.
Gordon Wilson
CEO of Advanced
Gordon is the Chief Executive Officer (CEO) of Advanced. Having joined the company in September 2015, he brings extensive experience in the software industry from which to continue to drive Advanced’s impressive growth trajectory. Gordon is leading Advanced’s ambitious transformation process which includes a four pillar process of reorganisation, rebranding, relocation and restructuring. With over 20 years’ General Management experience in the software and business support sectors, Gordon’s former roles include serving as Managing Director at Kerridge Automotive Systems, ADP Dealer Services and leading Aquila Heywood, the UK’s largest provider of pension and policy administration software and services.
Follow Gordon Wilson:
About Advanced: Advanced provide software & services for commercial, public and third sector organisations that make the complex simple.
Gordon Wilson
CEO of Advanced
Gordon is the Chief Executive Officer (CEO) of Advanced. Having joined the company in September 2015, he brings extensive experience in the software industry from which to continue to drive Advanced’s impressive growth trajectory. Gordon is leading Advanced’s ambitious transformation process which includes a four pillar process of reorganisation, rebranding, relocation and restructuring. With over 20 years’ General Management experience in the software and business support sectors, Gordon’s former roles include serving as Managing Director at Kerridge Automotive Systems, ADP Dealer Services and leading Aquila Heywood, the UK’s largest provider of pension and policy administration software and services.
Follow Gordon Wilson:
About Advanced: Advanced provide software & services for commercial, public and third sector organisations that make the complex simple.
Tess Cosad
Co-Founder & CEO of Bea Fertility
Tess Isabelle Cosad is the Chief Executive Officer and Co-Founder of Bea Fertility.
Follow Tess Cosad:
About Bea Fertility: Bea Fertility is a monthly subscription program that provides users with at-home fertility treatment and ovulation tracking.
Calvin Benton
Founder & CEO of Spill App
During university, Calvin took time out to learn the equivalent of a computer science degree in just a year, funded by a job-matching site and cake delivery firm he’d founded.
Follow Calvin Benton:
About Spill App: Spill is a startup that offers a message-based therapy app to help improve workplace well-being.
Zubair Ahmed
CEO & Founder of MedicSpot
Follow Zubair Ahmed:
About MedicSpot: MedicSpot gives patients convenient and quick access to healthcare using the latest advancements in telemedicine
Barney Gilbert
Founder, Co-CEO of Pando
Barney Gilbert worked in the NHS as a doctor before founding Pando, a healthtech company working to connect everyone working in healthcare. Listed in the UK’s Disruption50 Index for 2019. Forbes 30 Under 30 alum.
Follow Barney Gilbert:
About NHS England, Pando: Forward is now Pando! Pando is an essential tool for teamwork and secure collaboration in health and social care.
David Meinertz
CEO of Zava
David Meinertz (born 1974) is CEO of Europe’s largest online doctor Zava (previously DrEd). He founded Zava with Amit Khutti in 2010. Since the start of service in 2011 Zava has treated over three million patients across six European countries. Before Zava, the entrepreneur was responsible for the international expansion of a leading telemedicine company in the UK, and held a senior position in a European investor focused on small to mid-sized companies in the field of healthcare, technology and distribution. Meinertz is a lawyer and graduated with an MBA from HEC Paris. Together with his wife and three sons he lives in London.
Follow David Meinertz:
About Zava: Zava is an online medical service provider and offers consultations, diagnostics and medication without the need for a face-to-face visit.
Thom Jenkins
Founder & CEO of PetsApp
I am the Co-founder and CEO of PetsApp, a veterinary telemedicine platform enabling veterinary clinics to offer text chat, video consultations, digital payments and push notifications to pet owners. I have served as the Chief Operating Officer of multi-site private-equity backed veterinary groups in both Europe and Asia, operating clinics in Mainland China, Hong Kong, Singapore and the UK.
Follow Thom Jenkins:
About PetsApp: PetsApp provides an app-based client engagement platform for veterinary clinics, enabling them to better engage with pet owners.
Steve Miller
CEO of KoolZone
Follow Steve Miller:
About KoolZone: KoolZone offers real-time remote monitoring solutions for the hospitality and healthcare industry.
Rachael Corson
Co-Founder and CEO of Afrocenchix
Rachael Corson is a Co-Founder and CEO at Afrocenchix.
Follow Rachael Corson:
About Afrocenchix, Afrocenchix: Afrocenchix formulates, manufactures and sells safe, effective products for Afro & curly hair.
Phil Carr
Founder & CEO of My PT Hub
Phil Carr is the founder of My PT Hub.
Follow Phil Carr:
About My PT Hub: My PT Hub is an online web and mobile app, enabling personal trainers & fitness professionals to manage their clients.
Priti Padhy
Co-founder & CEO at Cognino AI of Cognino AI
Follow Priti Padhy:
About Cognino AI, ExtraaEdge: Cognino empowers Contextual decisions with Explainable AI. It transforms data at a cloud-scale into intelligence with speed and accuracy
Richard Vincent
CEO & Co-Founder of FundamentalVR
Richard has 20+ years’ experience of building international businesses and has throughout his career sought opportunities for positive market disruption through technological application. It was this desire that led him to co-found FundamentalVR to help address an age-old problem for the medical market; how to create safe, realistic, measurable spaces to learn and develop skills. In his role as CEO Richard is responsible for building a world class team of medical, learning and technologist who together can realise the company’s ambition of creating the world’s first global, haptically enabled, low cost ‘flight simulator for surgeons’.
Follow Richard Vincent:
About Fundamental Surgery, FundamentalVR: FundamentalVR delivers VR haptic ‘flight simulators’ for surgery creating a safe, measurable & repeatable space to refine to refine skills.
Paulina Chilarska
CEO & Founder of Cambridge Biolabs
Chilarska’s cutting-edge work at the University of Cambridge was funded by the prestigious 4-Year Wellcome Trust PhD award in Stem Cell Biology. Already at the age of 21 she worked with the Nobel Prize winner Sir Professor Paul Nurse on the cell cycle thus investigating the mechanisms underlying carcinogenesis. Dr Chilarska is an expert in the molecular basis of ageing and strongly believes that ageing is a disease which can be prevented and treated. She is currently wirting a book describing her revolutionary approach to Ageing Prevention and Ageing Reversal. She is fluent in five languages and has international consulting experience.
Follow Paulina Chilarska:
About Cambridge Biolabs: Biotech-meets-tech startup developing personalised skincare solutions
Tony de Fougerolles
Chief Executive Officer of Evox Therapeutics
Tony has been CEO of Evox Therapeutics since late 2017. He has 25 years of biotech R&D experience and has played a key role in developing and advancing three new drug modalities towards the market (mRNA, RNAi, Nanobodies). Previously, Tony was CSO of Ablynx, where he led the company’s non-clinical R&D operations and helped bring the 1st Nanobody drug, caplacizumab, to approval. Prior to Ablynx, Tony was the founding CSO at Moderna and pioneered modified mRNA as a new therapeutic modality for both rare diseases and as vaccines, including being the inventor of the mRNA chemistry and the foundational LNP formulations used in both the approved Moderna and Pfizer/BioNTech covid-19 vaccines. Prior to Moderna, Tony was among the first 6 employees at Alnylam and as VP Research helped develop RNAi as a new therapeutic modality, including overseeing the development of the now 1st approved LNP RNAi delivery system, and contributing to the development of several now approved RNAi drugs to treat life-threatening diseases. Tony has raised over $150m in equity financing, been the author on over $80m in grants, has over 60 scientific publications, and is an inventor on over 100 issued U.S. patents. He also serves on the Board of Walking Fish Therapeutics, is an advisor to and investor in multiple biotech companies, and is a Venture Partner at Ascension, a London-based venture capital firm. Lastly, he also volunteers his time with several non-profit organisations and charities. He earned his PhD in Immunology from Harvard University.
Follow Tony de Fougerolles:
About Evox Therapeutics: Evox Therapeutics is a biotechnology company that harnesses and engineer the natural trafficking capabilities of extracellular vesicles.
Stephanie Eltz
Co-founder, CEO of Doctify
Stephanie co-founded Doctify. She is the CEO of the company.
Follow Stephanie Eltz:
About Doctify: Doctify provides a solution for the millions of patients who want to search and compare healthcare and social care providers online.
Global CEO & Co-Founder of Andiamo
Follow Naveed Parvez:
About Andiamo, UnLtd: Custom medical wearables platform
Paulo Garcia
CEO & Co-Founder of Kytopen
Dr. Paulo A. Garcia co-invented the Flowfect™ technology while he was a Research Scientist at MIT. He is currently leading the development and commercialization efforts of the proprietary cell engineering platform for therapeutic and biotechnology applications.
Follow Paulo Garcia:
About Kytopen: Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Jarrett Bauer
Founder & CEO of Health Recovery Solutions
Jarrett Bauer joined Health Recovery Solutions as CEO and Co-Founder in 2012.
Follow Jarrett Bauer:
About Health Recovery Solutions: Health Recovery Solutions develops a cloud-based warning system to help users reduce readmissions for hospitals and ACOs.
Ian Nicholson
Chief Executive Officer of F2G
Ian joined Advent in 2012 from Chroma Therapeutics Limited, a privately held oncology-focussed R&D company, where he served as Chief Executive Officer for eight years. Prior to joining Chroma, Ian was Senior Vice President, Business Development at Celltech Group plc, then the UK’s largest biotechnology company. He has extensive experience in licensing, mergers and acquisitions, and market development in the UK, Europe and the US. Ian has held a variety of senior commercial positions with Oxford Asymmetry International plc, Lonza AG and Amersham International plc and currently sits on the Boards of Consort Medical plc, Clinigen Group plc and is Non-Executive Chairman of Bioventix plc. Ian holds a B.Sc. (Hons.) degree from University College London and an MBA from Boston University. Ian is CEO of F2G Ltd and an advisor to NeRRe Therapeutics.
Follow Ian Nicholson:
About Advent Life Sciences, Amersham International, F2G: F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.
Alex Hind
CEO & Co-Founder of Heka
Alex Hind, CEO & Co-Founder of GoSweat.
Follow Alex Hind:
About Heka: The personalised health platform to make your employees feel valued.
